Drug reference index
SemaglutideGLP-1 receptor agonist used for type 2 diabetes (Ozempic), chronic weight management with cardiovascular risk reduction Ozempic
Brand name for semaglutide, FDA-approved for type 2 diabetes mellitus. Same active ingredient as Wegovy and Rybelsus. Wegovy
Brand name for semaglutide 2.4 mg, FDA-approved for chronic weight management and cardiovascular risk reduction in adult Rybelsus
Brand name for oral semaglutide, FDA-approved for type 2 diabetes mellitus. Daily tablet (3, 7, 14 mg). Compounded Semaglutide
Patient-specific or office-stock semaglutide preparation dispensed by a 503A licensed compounding pharmacy or 503B FDA-r Tirzepatide
Dual GLP-1/GIP receptor agonist. Brand names: Mounjaro (T2D), Zepbound (chronic weight management; OSA in adults with ob Mounjaro
Brand name for tirzepatide, FDA-approved for type 2 diabetes mellitus. Zepbound
Brand name for tirzepatide, FDA-approved for chronic weight management and obstructive sleep apnea in adults with obesit Liraglutide
Daily GLP-1 receptor agonist. Brand names: Victoza (T2D), Saxenda (chronic weight management). Older agent, lower weight Saxenda
Brand name for liraglutide 3.0 mg daily, FDA-approved for chronic weight management. Victoza
Brand name for liraglutide 1.8 mg daily, FDA-approved for type 2 diabetes mellitus. Dulaglutide
Weekly GLP-1 receptor agonist. Brand name: Trulicity. FDA-approved for type 2 diabetes mellitus.
Tirzepatide family
- Tirzepatide reference
- Mounjaro® (T2D)
- Zepbound® (chronic weight management, OSA)
- Compounded tirzepatide
Semaglutide family
- Semaglutide reference
- Ozempic® (T2D)
- Wegovy® (chronic weight management, CV)
- Rybelsus® (oral T2D)
- Compounded semaglutide